Future Outlook of the Head And Neck Cancer Diagnostics Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the head and neck cancer diagnostics market size evolved in recent years?
In the past few years, the market size for head and neck cancer diagnostics has experienced significant growth. Expected to increase from a size of $1.74 billion in 2024 to a size of $2.05 billion in 2025, it boasts a compound annual growth rate (CAGR) of 17.4%. The growth observed in the historic period can be traced back to factors such as tobacco and alcohol use, an upsurge in the aging population, awareness building campaigns, advancements in biopsy techniques, and development in healthcare infrastructure.
What are the predictions for the head and neck cancer diagnostics market size in the coming years?
The market size for head and neck cancer diagnostics is projected to experience a swift expansion in the coming years, reaching a value of $3.87 billion in 2029 with a compound annual growth rate (CAGR) of 17.3%. This forthcoming growth can be linked to factors such as genomic biomarkers, an increase in hpv-related cancers, the use of artificial intelligence (ai), immunotherapy and targeted therapy, as well as alterations in healthcare policies and reimbursements. The forecast period will also be influenced by major trends like the prevalence of liquid biopsy, multi-modality diagnostics, point-of-care diagnostics, global alliances and collaborations, and digital pathology integration.
Get your head and neck cancer diagnostics market report here!
What key factors are fueling the growth of the head and neck cancer diagnostics market?
The surge in head and neck cancer incidents is anticipated to drive the expansion of the head and neck cancer diagnostics market. Head and neck cancer comprises a group of tumors impacting the tissues and organs in the head and neck area. These include the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Diagnostics for head and neck cancer aids in the early disease detection through a variety of tests such as an incisional biopsy and a barium swallow test. For example, in February 2023, as per the American Society of Clinical Oncology, a professional organization for doctors and oncology experts based in the US, head and neck cancer accounted for 4% of all US malignancies. It is forecasted that head and neck cancer will affect 66,920 individuals in the USA in 2023, comprising 49,190 men and 17,730 women. Globally, in 2020, the number of people affected by head and neck cancer was 562,328. Moreover, statistics from Australia reveal that there were 5,189 new cases of head and neck cancer in 2022. Thus, the escalation in the occurrence of head and neck cancer is fueling the advance of the head and neck cancer diagnostics market.
How is the global head and neck cancer diagnostics market divided into key segments?
The head and neck cancer diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users
Subsegments:
1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays
2) By Endoscopy Screening Equipment: Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems
3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Dental Diagnostic Methods: Intraoral Cameras, Dental X-rays, Oral Cancer Screening Devices
5) By Other Diagnostic Methods: Molecular Diagnostics, Blood Tests, Genetic Testing
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12016&type=smp
Who are the key firms paving the way for growth in the head and neck cancer diagnostics market?
Major companies operating in the head and neck cancer diagnostics market include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.
Which trends are expected to transform the head and neck cancer diagnostics market?
The crucial trend of product innovation is making a mark in the head and neck cancer diagnostics arena, with major companies gearing up to introduce unique products that can bolster their market standing. In this context, Alkem Laboratories Ltd., hailing from India, made headlines when they launched Cetuxa, the world’s first biosimilar product for treating head and neck cancer in May 2023. Embedded with anti-tumor properties, Cetuxa is a biosimilar to cetuximab – a monoclonal antibody that restricts the receptor-dependent transduction pathway. Cetuximab links to the extracellular domain of the epidermal growth factor receptor (EGFR). Cetuximab is often used in conjunction with chemotherapy or radiation therapy in clinical setups. It finds application in managing locally advanced, relapsed or metastatic squamous cell carcinoma of the head and neck.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12016
What regions are contributing significantly to the growth of the head and neck cancer diagnostics market?
North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Epoxy Resin Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/epoxy-resin-global-market-report
Epoxy Adhesives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/epoxy-adhesives-global-market-report
Reactive & Other Adhesives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/reactive-and-other-adhesives-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
